Amy Schumer Comforts Her Father Who is Living With MS 

Amy Schumer Comforts Her Father Who is Living With MS HER AMY IS TRUEComedian Amy Schumer is pulling out all the stops to help her...
video

Faith Donald Anderson – Voices For Faith

Faith Donald Anderson - Voices For Faith For 25 years, I was a professional performing artist until:My Story Begins....with the birth of my son Darios....

Advanced Practice Providers Treat Significantly More of their Multiple Sclerosis Patients with Monoclonal Antibody...

Market access restrictions for high efficacy Multiple Sclerosis therapies may be hindering their ability to optimally treat their clinically complex, relapsing patients, according to...

Neural Skin Cells May One Day Repair CNS Nerve Damage from Multiple Sclerosis

A personalized treatment for multiple sclerosis may be one step closer, thanks to a new study that reveals how a person's own skin cells...

New Inroads Against Multiple Sclerosis

JAMA recently published their interviews with two MS Specaists focusing on the medical progress against multiple sclerosis (MS) in 2017 with the approval by the...

How did doctors get it so wrong for 20 years?

How did doctors get it so wrong for 20 years? That's how long Made In Chelsea star Jane complained of fatigue and aching joints...

Biogen, AbbVie yank multiple sclerosis drug Zinbryta off global market

Zinbryta (daizumab) was flagged by European regulators with a lethal safety warning over cases of encephalitis and meningoencephalitis. Evaluating the drug's "complex and evolving...

Roche seeks partners for remyelination therapies

Roche Holding AG is seeking a partner with experimental drugs that might help repair the damage caused to the nervous system by multiple sclerosis...

Health Canada approval last week of multiple sclerosis drug ‘absolutely a game-changer’

Global News - Joseph Petrilli said he cried for a long time when he heard that Health Canada approved a new drug that could...

Biogen’s 8% Increase to Some MS Medications Could Provide a Boost in 2018

Market Watch reports Biogen Inc.'s BIIB, +4.90% recent price increases on multiple sclerosis drugs "could provide lift into '18," according to RBC Capital Markets...

Social Media

834FollowersFollow